1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Autoimmune Drug Focus JANUARY 2016

Autoimmune Drug Focus JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - IBD Research Set To Benefit From Synchronicity In 2016
Industry Trend Analysis - Afrezza Agreement Termination An Opportunity Rather Than An Obstacle
Industry Brief - FDA Approves Humulin R U-500 KwikPen
Industry Brief - Novo Nordisk Launches Tresiba In US
Industry Brief - Gilead Terminates Simtuzumab Phase II Study In IPF
Industry Brief - Data From Biosimilar Infliximab Study Presented
Industry Brief - Enrolment Begins In Phase II Trial Of Cytori Cell Therapy In CD
Industry Brief - GeNeuro Initiates GNbAC1 Phase IIb Trial In RRMS
Industry Trend Analysis - Laquinimod Viability In Doubt
Industry Brief - EMD Serono Takes Exclusive Promotion Of Rebif In US
Industry Brief - Can-Fite Submits CF101 Phase III Protocol To IRB In RA
Industry Brief - FDA Accepts Sarilumab BLA For Review
Industry Brief - AbbVie Initiates Phase III Trial Programme Of ABT-494 In RA
Industry Brief - Sorrento Biosimilars Show Positive Phase III Results
Industry Brief - Health Canada Approves Stelara For Moderate-To-Severe Psoriasis In Adolescents
Industry Brief - Torrent Launches Adalimumab Biosimilar
Industry Trend Analysis - Marketing Will Be Key To Creating A Viable Biosimilar Etanercept Niche
Industry Brief - Milestone Triggered As Lilly Submits Baricitinib NDA To FDA For RA
Company Brief - Positive Phase III Results Reported For CHS-0214
Industry Brief - FDA Accepts Amgen's Biosimilar Adalimumab For Review
Industry Brief - FDA Approves Consentyx For AS/PsA
Industry Brief - FDA Accepts Brodalumab BLA For Review In Plaque Psoriasis
Industry Brief - Neovacs Secures Funds To Support Development Of IFN Kinoid
Industry Brief - FTC Clears Galapagos/Gilead Filgotinib Partnership
Industry Brief - Galapagos/Gilead Complete Closing Of Filgotinib Collaboration
Industry Brief - Stellar/Neovacs Form JV To Produce Conjugated Therapeutic Vaccines
Industry Brief - Autoimmune Conferences - April 2016

Table Of Contents

Autoimmune Drug Focus JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...


Download Unlimited Documents from Trusted Public Sources

Biosimilar Industry in Europe

  • November 2016
    42 pages
  • Biosimilar  

  • Europe  

View report >

Pathology Statistics in Canada

  • October 2016
    2 pages
  • Biosimilar  

  • Canada  

    North America  

View report >

Global Breast Cancer Statistics

  • October 2016
    2 pages
  • Breast Cancer  

    Biosimilar  

  • Europe  

    World  

    Hungary  

View report >

Bioprocessing Industry

3 months ago

Biosimilar Statistics

3 months ago

Biosimilar Statistics

3 months ago

Related Market Segments :

Biosimilar

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.